Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (231-240 of 484) with videos related to

Pageof 49
Sort By:
The Journal of Investigative Dermatology|June 10, 2011
Loss of PTEN expression by dermal fibroblasts causes skin fibrosisSunil K Parapuram, Xu Shi-wen, Christopher Elliott, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic SclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Rheumatology (Oxford, England)|February 8, 2018
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosisOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Scientific Reports|February 25, 2017
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic SclerosisJohannes P Schwaiger, Christopher D Loder, David Dobarro, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptorRachel K Hoyles, Emma C Derrett-Smith, Korsa Khan, et al.
The European Respiratory Journal|March 23, 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosisJ Gerry Coghlan, Matthias Wolf, Oliver Distler, et al.
The Lancet. Rheumatology|July 27, 2022
Systemic sclerosis in the time of COVID-19Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, et al.
Arthritis and Rheumatism|January 1, 2009
Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblastsXu Shi-wen, Sunil K Parapuram, Daphne Pala, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
ReplyRobyn T Domsic, Mary Lucas, Svetlana I Nihtyanova, et al.
Fibrogenesis & Tissue Repair|April 2, 2011
Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanismYunliang Chen, Andrew Leask, David J Abraham, et al.
Pageof 49

Showing results (231-240 of 484) with videos related to

Sort By:
Pageof 49
The Journal of Investigative Dermatology|June 10, 2011
Loss of PTEN expression by dermal fibroblasts causes skin fibrosisSunil K Parapuram, Xu Shi-wen, Christopher Elliott, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic SclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Rheumatology (Oxford, England)|February 8, 2018
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosisOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Scientific Reports|February 25, 2017
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic SclerosisJohannes P Schwaiger, Christopher D Loder, David Dobarro, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptorRachel K Hoyles, Emma C Derrett-Smith, Korsa Khan, et al.
The European Respiratory Journal|March 23, 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosisJ Gerry Coghlan, Matthias Wolf, Oliver Distler, et al.
The Lancet. Rheumatology|July 27, 2022
Systemic sclerosis in the time of COVID-19Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, et al.
Arthritis and Rheumatism|January 1, 2009
Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblastsXu Shi-wen, Sunil K Parapuram, Daphne Pala, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
ReplyRobyn T Domsic, Mary Lucas, Svetlana I Nihtyanova, et al.
Fibrogenesis & Tissue Repair|April 2, 2011
Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanismYunliang Chen, Andrew Leask, David J Abraham, et al.
Pageof 49